Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Noetik, a Bay Area startup founded by former Recursion executives, has successfully raised an oversubscribed $40 million in a Series A funding round. The funding will be used to advance Noetik's clinical translation AI models for cancer treatment. The round was led by Amy Schulman from Polaris Partners, providing significant validation for Noetik's platform.
Congrats to @ron_alfa, Jacob Rinaldi, and the entire @noetik_ai team on their oversubscribed Series A! Since leading the Seed round, I have been blown away by their speed of execution Excited to work with Amy Schulman @ Polaris as NOETIK accelerates into the next stage https://t.co/ZTEBQ6StaE
Huge congrats to @DCVC #techbio company @noetik_ai on its $40M Series A to scale its clinical translation AI models for cancer. @PolarisVC leading the round is tremendous validation for the platform. Well done @ron_alfa , Jacob Rinaldi & team! https://t.co/qm1PyKwRci
Our team is beyond excited to announce our oversubscribed $2M pre-seed round from a world-class group of investors! To learn more, visit https://t.co/UyHqoaT9mA! 🇺🇸 #GovCon #DefenseTech #GovTech #Procurement #Acquisition #NDAA #AI https://t.co/xWnwQW0Gx2
